<![CDATA[21 Body Mass Index and Its Association With Pathological Response in Breast Cancer Patients in Venezuela]]>

Neutral

AI Analysis

Summary

Study of 391 Venezuelan breast cancer patients receiving neoadjuvant chemotherapy found that normal BMI was associated with higher pathological complete response rates and better overall survival at 120 months compared to overweight and obese patients.

Clinical Trial Data

Patients

391

Importance:2/10

Sentiment:

0.00

breast cancerneoadjuvant chemotherapyBMIpathological complete responseobservational study

Read the original article

Published by Cancer Network on July 7, 2026 10:00 PM

Read Original